Shanghai Sailun Biotechnology Co., Ltd
Initial public offering and listing on the science and Innovation Board
Announcement of issuance results
Sponsor (lead underwriter): Founder Securities Co.Ltd(601901) underwriting sponsor Co., Ltd
The application for initial public listing of biological shares (hereinafter referred to as “A shares”) on the Shanghai Stock Exchange (hereinafter referred to as “common stock”) has been reviewed and approved by the Shanghai branch stock exchange (hereinafter referred to as “A shares”) and the Shanghai Stock Exchange (hereinafter referred to as “common stock”), The registration has been approved by the China Securities Regulatory Commission in the document of Zheng Jian Ke Ke [2022] No. 204. The sponsor (lead underwriter) of this offering is Founder Securities Co.Ltd(601901) underwriting sponsor Co., Ltd. (hereinafter referred to as “founder sponsor” and “sponsor (lead underwriter)”). The issuer’s stock is referred to as “Salem biology” for short, and its expansion is referred to as “Salem biology” for short, with the stock code of “688163”.
This offering is conducted by a combination of directional placement to strategic investors (hereinafter referred to as “strategic placement”), offline inquiry placement to qualified investors (hereinafter referred to as “offline issuance”), and online pricing issuance to social public investors holding non restricted A-share shares and non restricted depositary receipts market value in Shanghai market (hereinafter referred to as “online issuance”). According to the preliminary inquiry results, the issuer and the recommendation institution (lead underwriter) comprehensively consider the issuer’s fundamentals, industry, market conditions, valuation level of comparable companies, demand for raised funds and other factors, and negotiate to determine that the issuance price is 33.03 yuan / share, and the issuance quantity is 27.06 million shares, all of which are new shares without transfer of old shares.
The initial strategic placement of this offering is expected to issue 1353000 shares, accounting for 5.00% of the total number of this offering. The subscription funds promised by the strategic investors have been fully remitted to the bank account designated by the sponsor (lead underwriter). The final number of strategic allotments in this issuance is 1211020 shares, accounting for 4.48% of the total number of this issuance. The difference between the initial number of strategic allotments and the final number of strategic allotments is 1419800 shares, which are transferred back to offline issuance.
After the callback of strategic placement and before the launch of online and offline callback mechanism, the number of offline issuance was 181369800 shares, accounting for 70.17% of the number issued after deducting the final number of strategic placement; The number of shares issued online was 7.712 million, accounting for 29.83% of the number issued after deducting the final strategic placement. The total number of shares issued offline and online was 25848980.
According to the announcement on the IPO arrangement and preliminary inquiry of Shanghai Salem Biotechnology Co., Ltd. and the announcement on the IPO and listing of Shanghai Salem Biotechnology Co., Ltd. on the science and Innovation Board (hereinafter referred to as the “issuance arrangement and preliminary inquiry announcement”) and the announcement on the IPO and listing of Shanghai Salem Biotechnology Co., Ltd. on the science and Innovation Board (hereinafter referred to as the “issuance announcement”) According to the announced callback mechanism, since the initial effective subscription multiple of this online offering is 460430 times, higher than 100 times, the issuer and the sponsor (lead underwriter) decided to start the callback mechanism, adjust the scale of offline and online issuance, and callback 2.585 million shares (rounded up to an integral multiple of 500 shares) from offline to online. After the callback mechanism was launched, the final number of offline shares issued was 155519800, accounting for 60.16% of the total issued after deducting the number of strategic placements; The final number of shares issued online was 10.297 million, accounting for 39.84% of the total issued after deducting the number of strategic placements.
After the callback mechanism was launched, the final winning rate of online issuance was Impulse (Qingdao) Healthtechco.Ltd(002899) 879%.
The online and offline subscription and payment work of this offering has been completed on March 2, 2022 (T + 2). 1、 Statistics of new share subscription
According to the payment of the strategic investors and the data provided by Shanghai Stock Exchange and China Clearing Shanghai Branch, the sponsor (lead underwriter) made statistics on the subscription of new shares issued online and offline. The results are as follows: (I) strategic placement
The strategic placement of this offering is that the relevant subsidiaries of the sponsor participate in the follow-up investment, and the follow-up investment institution is Founder Securities Co.Ltd(601901) Investment Co., Ltd. (hereinafter referred to as “founder investment”). There is no special asset management plan for senior executives and core employees and other strategic investor arrangements.
The payment and placement of the strategic placement of this offering have been completed, and the strategic investors of this offering have participated in the strategic placement of this offering as promised. It is confirmed that the strategic investors disclosed in the issuance announcement participate in the strategic placement of this issuance effectively. The recommendation institution (lead underwriter) has returned the excess amount of the initial payment of the strategic investor exceeding the corresponding amount of the final allocated shares before March 4, 2022 (T + 4). The final situation of the strategic placement of this offering is as follows:
Investor name number of allocated shares allocated amount (yuan, total of new share placement brokers (yuan) restricted period (shares) (excluding Commission) Commission (yuan) (month)
Founder Securities Co.Ltd(601901) investment 12110203999999060 – 3999999060 24
Limited company
Total 12110203999999060 – 3999999060-
(II) online subscription of new shares
1. Number of shares subscribed by online investors: 10252311 shares
2. Subscription amount paid by online investors: 33863383233 yuan
3. Number of online investors giving up subscription: 44689 shares
4. Subscription amount abandoned by online investors: 147607767 yuan (III) subscription of offline new shares
1. Number of shares subscribed by offline investors: 15551980 shares
2. Subscription amount paid by offline investors: 51368189940 yuan
3. Number of offline investors giving up subscription: 0 shares
4. Subscription amount abandoned by offline investors: 0 yuan
5. Brokerage commission for placement of new shares paid by offline investors: 256842036 yuan. 2、 Offline placement lottery
In accordance with the issuance announcement, the issuer and the recommendation institution (lead underwriter) conducted a lottery ceremony for the offline placement of shares of Shanghai Sailun Biotechnology Co., Ltd. in the morning of March 3, 2022 (T + 3) at the Haitang hall, the conference room on the fourth floor of Zijinshan Hotel, 778 Dongfang Road, Pudong, Shanghai. The lottery ceremony was conducted in accordance with the principles of openness, fairness and impartiality. The process and results of the lottery have been notarized by Shanghai Oriental notary office.
The winning results are as follows:
Last digit winning lot number
Last “1” digit 8
Last “4” digit 0580
Securities investment funds and other partial stock asset management products established by participating in offline issuance, subscription and allocation of Salem biological shares, basic endowment insurance funds, social security funds managed by social security fund investment managers, enterprise annuity funds established in accordance with the measures for the administration of enterprise annuity funds If the mantissa of the subscription allotment number held by the placement objects such as insurance funds and qualified foreign institutional investor funds that comply with the Interim Measures for the administration of the use of insurance funds is the same as the above number, it is the winning number.
A total of 3185 accounts participated in the offline placement and lottery, and the number of accounts corresponding to 10% of the final allocated accounts (rounded up) is 319. According to the lottery results, all the winning accounts have obtained the shares for this placement, and the sales restriction period is 6 months. The number of shares corresponding to this part of the account is 1085376, accounting for 6.98% of the total offline issuance and 4.20% of the total public offering after deducting the number of strategic placement. Please refer to the “attached table: table of lottery results of offline placement” for the specific conditions of the placing objects who won the lottery in this offline lottery.
3、 Underwriting by the recommendation institution (lead underwriter)
The number of shares abandoned by online and offline investors is underwritten by the sponsor (lead underwriter). The number of shares underwritten by the sponsor (lead underwriter) is 44689, and the underwriting amount is 147607767 yuan. The proportion of the number of underwritten shares in the issuance after deducting the final strategic placement is 0.1729%, The proportion of the number of underwritten shares in the total number of shares issued this time is 0.1651%.
On March 4, 2022 (T + 4), the recommendation institution (lead underwriter) will transfer the underwriting funds, the funds paid and subscribed by strategic investors and online and offline investors to the issuer together after deducting the recommendation underwriting fee and the brokerage commission of new share placement. The issuer will submit the application for share registration to China Clearing Shanghai Branch, Register the underwritten shares in the securities account designated by the sponsor (lead underwriter). 4、 Contact information of sponsor (lead underwriter)
If online and offline investors have any questions about the issuance results announced in this announcement, please contact the sponsor (lead underwriter) of this issuance. The specific contact information is as follows:
Sponsor (lead underwriter): Founder Securities Co.Ltd(601901) underwriting sponsor Co., Ltd
Contact: equity capital market department
Tel: 01056991830, 01056991832
Issuer: sponsor (lead underwriter) of Shanghai Sailun Biotechnology Co., Ltd.: Founder Securities Co.Ltd(601901) underwriting sponsor Co., Ltd. March 4, 2022 (no text on this page) Seal page of announcement on the results of initial public offering and listing on the science and Innovation Board of Shanghai Sailun Biotechnology Co., Ltd.)
Issuer: Shanghai Sailun Biotechnology Co., Ltd. (no text on this page, which is the seal page of the announcement on the results of Shanghai Sailun Biotechnology Co., Ltd. initial public offering and listing on the science and Innovation Board)
Sponsor (lead underwriter): Founder Securities Co.Ltd(601901) underwriting sponsor Co., Ltd. mm / DD / yyyy
Attached table: lottery results of offline placement
Serial number name of investor name of placing object name of placing object account placing quantity restriction period (shares) (month)
1 China Europe Fund Management Co., Ltd. China Europe emerging value one-year holding hybrid securities d8902928943607 6 Investment Fund
2 Europe Fund Management Co., Ltd. China Europe research selected hybrid securities investment fund d8902652953607 6
3 China Europe Fund Management Co., Ltd. China Europe innovation closed operation hybrid d8902411283607 6 Securities Investment Fund in the next 18 months
4 China Europe Fund Management Co., Ltd. China Europe science and technology innovation theme 3-year closed operation flexible configuration d8901809663607 6 hybrid securities investment fund
5 China Europe Fund Management Co., Ltd. China Europe Jiaze flexible allocation of hybrid securities investment fund d8901170283607 6
6 China Europe Fund Management Co., Ltd. China Europe Jintong flexibly allocates hybrid securities investment fund d89 Ife Elevators Co.Ltd(002774) 43607 6
7 China Europe Fund Management Co., Ltd. China Europe Shengshi growth graded stock securities investment fund d8907920433607 6
8 Tianhong Fund Management Co., Ltd. Tianhong CSI food and beverage trading open-end index d8902759233607 6 Securities Investment Fund
9 Tianhong Fund Management Co., Ltd. Tianhong Yixin hybrid securities investment fund d8902592783607 6
ten
